Navigation Links
Instrumentation Laboratory Announces 'Passion & Results' Award Winners
Date:9/21/2009

BEDFORD, Mass., Sept. 21 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced the three recipients of their "Passion & Results" Award. The winners were presented with their awards by IL during ceremonies at the Congress for the International Society on Thrombosis and Haemostasis (ISTH) held in Boston, MA, July 11-16 and at the Annual Meeting for the American Association for Clinical Chemistry (AACC), in Chicago, IL, July 19-23.

The "Passion & Results" Award honors healthcare providers who have demonstrated true passion for their profession, resulting in improved patient care. The Company received an overwhelming number of nominations for professionals involved in Critical Care and Hemostasis diagnostics, all around the world.

Though each of the many nominations received were significant and compelling, three nominees truly exemplified uncommon effort and energy, and were chosen to receive an award plus a $2,000 educational grant for their institution in recognition of their 'passion and results.' The three winners were:

    Dr. Cesare Manotti
    President  of the  Italian Federation of Centers for the Surveillance of
    Anticoagulant therapies (FCSA)
    Milan, Italy

    Giacinto Gervasi, MS, MT(ASCP)
    Lead Technologist
    Laboratory Department
    Syosset Hospital
    Syosset, NY

    Diane Davis, MT(ASCP)SH
    Clinical Laboratory Specialist
    Pathology/Laboratory Medicine
    All Children's Hospital
    St Petersburg, FL

Dr. Cesare Manotti, a scientist with a true passion for research, stood out for his ability to develop new tools and processes in diagnostics to better patient care. In 1983, Dr. Manotti pioneered the development of PARMA OAT Software and contributed heavily to quantifiably improving Oral Anticoagulant Therapy (OAT) quality throughout Europe with PARMA and other related software. He continues to improve the PARMA OAT Software and, most recently, he has been contributing to the development of the new PARMA 6. We honor him for his dedication to the continuous improvement of patient care.

Mr. Gervasi was chosen for an exemplary career as a Laboratory Technologist and for his unwavering work ethic. His career began in 1966, and ever since, he has been recognized as being "invaluable to the lab" for his intelligence, enthusiasm, good judgment, and for being a resource for the entire staff. Mr. Gervasi's hard work, dedication and attention to detail, has provided the patients of Syosset Hospital with the best in diagnostic testing.

Ms. Davis, exemplifies the pioneering Point-of-Care (POC) Coordinator, developing an entire POC testing program - from scratch and with no set of directions or an existing model. Davis's point-of-care-testing (POCT) program, initiated in 1994, has been heralded as "one of the best in the US." It provides testing for three pediatric ICUs, an 80-bed Neonatal ICU, a Cardiovascular OR, the Cath Lab, and the Emergency Room. Physicians and nurses at All Children's use POCT tools so effortlessly now, they have come to take POCT for granted - Diane's goal all along.

"IL is proud to honor these inspiring individuals who exhibit remarkable passion and an unmatched commitment to achieving the best results for their patients," said Josep Manent, CEO at IL. "We salute the outstanding achievements of Diane Davis, Giacinto Gervasi, and Dr. Cesare Manotti."

Ramon Benet, Vice President of Worldwide Marketing and US Sales and Service at IL, added, "At IL, we reflect passion and results in all we do and have the unwavering goal of improving the quality of patient care. We are honored to recognize and reward this same passion for results in the healthcare professionals we serve."

Part of IL's 50th Anniversary Celebration

The 'Passion & Results' Award is the cornerstone of IL's comprehensive '50 and Forward' program, a celebration of the Company's 50th anniversary. The '50 and Forward' program of events and activities was officially launched at last year's AACC Conference. For details and more information on our winners and their stories, visit www.ilus.com/50forward.

About Instrumentation Laboratory

Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM(R) product offerings, part of the critical care line, include the new GEM Premier 3500 with Intelligent Quality Management (iQM(R)), GEM Premier(TM) 4000 analyzer with iQM, GEMweb Plus information management system, and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP(R) Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the new ACL TOP 700, the new ACL TOP 700 LAS and the ACL TOP 500 CTS. IL also offers the new ACL AcuStar(TM), ACL ELITE(R)/ELITE PRO, other hemostasis analyzers and the HemosIL(R) line of reagents. IL is based in Bedford, Massachusetts.

The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL TOP, ACL ELITE, ACL AcuStar and Premier are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.


'/>"/>
SOURCE Instrumentation Laboratory
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
2. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
3. Instrumentation Laboratory Launches ACL Top(R) 500 CTS Hemostasis Testing System
4. Instrumentation Laboratory Receives Performance Award from Premier for Second Consecutive Year
5. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
6. Instrumentation Laboratory Announces ILeader Panel of Experts as Part of 50th Anniversary Program
7. Instrumentation Laboratory Wins Extended Agreement With MedAssets Supply Chain Systems for Critical Care Portfolio
8. Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics
9. Instrumentation Laboratory Launches ACL AcuStar(TM) Hemostasis Testing System
10. Instrumentation Laboratory Receives 510(k) Clearance From FDA for HemosIL(R) Liquid Heparin Assay
11. Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc. and Life Technologies Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles on his ... the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his family ... hospital’s 30th heart transplant recipient. , “He was playing at home, when we got ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... One ... regular changing of the securement tape is painful for her. "This is why the ... to patients’ heads," she said. , They then created a prototype of the patent-pending ...
(Date:12/7/2016)... ... December 07, 2016 , ... The Honolulu cosmetic and ... website, which launched October 17, 2016, features comprehensive information regarding a wide range ... Visitors and patients can discover the latest clinical dermatology treatments for medical skin ...
(Date:12/7/2016)... ... , ... The medical profession is well aware that heart attacks do indeed ... heart attacks among 138,602 people recorded a 35% higher number of heart attacks in ... of course–no time of year is a good time for a heart attack! In ...
(Date:12/7/2016)... ... December 07, 2016 , ... “The Road To Restoration”: ... trial, not a one hour a week showing of hands. “The Road To Restoration” ... begins, “Perhaps you are familiar with the brass ring that you could reach out ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... 2016   Arena Pharmaceuticals, Inc. (NASDAQ: ... enrollment in the ralinepag phase 2 trial.  Ralinepag is ... pathway for the treatment of pulmonary arterial hypertension (PAH). ... "This marks an important step in the ... focus on our pipeline," said Amit Munshi , ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 According to ... in more than one-third (38%) of patients with non-small cell ... epidermal growth factor receptor (EGFR) genetic mutation status. The findings ... ( LBA ID #6067 #P3.02b ) at the ... Vienna, Austria . The survey results revealed ...
(Date:12/7/2016)... 7,2016  Based on its recent analysis ... & Sullivan recognizes Nemaura Pharma Limited with ... for Enabling Technology Leadership. Nemaura Pharma,s transdermal ... traditional drug delivery technologies, especially in delivering ... delivery technologies, Memspatch and Micropatch respectively, facilitate ...
Breaking Medicine Technology: